Cas No.: 137813-35-5
PRODUCT INFORMATION
Description
Cyclo(Arg-Gly-Asp-D-Phe-Val) (cRGDfV) is a cyclic pentapeptide that functions as a potent and selective integrin αvβ3 antagonist. It is a widely used research tool for disrupting integrin-mediated cellular adhesion, migration, and signaling pathways in vitro. Its enhanced structural stability makes it valuable for research targeting αvSβ3-overexpressing cells, including applications in various oncology cell models.
Molecular Weight
574.63
Purity
> 95%
Formula
C₂₆H₃₈N₈O₇
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Val]
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- Bonemarrow-Derived Mesenchymal Stem Cells Affinity Peptide (CAT#: OLY-1025-YS-44)
- Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) Targeting Peptide (CAT#: OLY-1025-YS-62)
- Cyclo(RGDyK) TFA Targeting Peptide (CAT#: OLY-1025-YS-54)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.